Twitter
Google plus
Facebook
Vimeo
Pinterest

Fluid Edge Themes

Title Image

Media

Company News

Authority Magazine - 07-18-2020

The Future Of Beauty: Stem Cell Technology To Improve Skin And Hair, With Habib Torfi of Invitrx Therapeutics

Invitrx began as a developer of skin grafts for burn patients. We developed one of the first umbilical cord blood stem cell products. As this product was unique and the market was immature the demand for the product grew exponentially.

Read more

Bio Informant - 09-24-2020

Invitrx Therapeutics to Co-Sponsor Baylx, Inc’s US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Mesenchymal stem cells hold great promise to treat COVID-19 patients due to their potential in inhibiting the overactivated immune system and promoting the recovery of pulmonary

Read more

Access Wire - 10-07-2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics' continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company's collaboration with Baylx, Inc.

Read more

Yahoo Finance - 10-08-2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics' continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company's collaboration with Baylx, Inc.

Read more

Apnews - 10-08-2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc’s US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience in the harvesting and isolation of stem cells for the discovery

Read more

Science tech - 10-07-2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience in the harvesting and isolation of stem cells for the discovery

Read more

21 Wfmj - 10-07-2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics' continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company's collaboration with Baylx, Inc.

Read more

Fox34 - 10-07-2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience in the harvesting and isolation

Read more

Digital Journal - 10-07-2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics' continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company's collaboration with Baylx, Inc. (Baylx) to co-sponsor and spearhead the clinical trial

Read more

Headline Tech - 10-07-2020

Invitrx Therapeutics Profiled On BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product For COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience in the harvesting and isolation of stem cells for the discovery, development

Read more

Asean Coverage - 10-07-2020

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience in the harvesting and isolation of stem cells for the discovery, development

Read more

Daily Tech Geek - 10-07-2020

INVITRX THERAPEUTICS PROFILED ON BIOINFORMANT ABOUT CO-SPONSORING BAYLX, INC'S US FDA APPROVED UMBILICAL CORD TISSUE MESENCHYMAL STEM CELLS PRODUCT FOR COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience in the harvesting and isolation of stem cells for the discovery, development

Read more

The Scientific Journal - 10-07-2020

Invitrx Therapeutics Profiled On BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product For COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience in the harvesting and isolation of stem cells for the discovery, development

Read more